Cite
HARVARD Citation
Chardin, D. et al. (2020). Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study. Journal for immunotherapy of cancer. 8 (2), p. . [Online].